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ABSTRACT: Fcγ receptors are a family of cell–surface
receptors that are expressed by a host of different in-
nate and adaptive immune cells, and mediate inflamma-
tory responses by binding the Fc portion of immunoglob-
ulin G. In humans, five low-affinity receptors are encoded
by the genes FCGR2A, FCGR2B, FCGR2C, FCGR3A,
and FCGR3B, which are located in an 82.5-kb segmen-
tal tandem duplication on chromosome 1q23.3, which
shows extensive copy-number variation (CNV). Deletions
of FCGR3B have been suggested to increase the risk of
inflammatory diseases such as systemic lupus erythemato-
sus and rheumatoid arthritis (RA). In this study, we iden-
tify the deletion breakpoints of FCGR3B deletion alleles
in the UK population and endogamous native American
population, and show that some but not all alleles are
likely to be identical-by-descent. We also localize a du-
plication breakpoint, confirming that the mechanism of
CNV generation is nonallelic homologous recombination,
and identify several alleles with gene conversion events
using fosmid sequencing data. We use information on the
structure of the deletion alleles to distinguish FCGR3B
deletions from FCGR3A deletions in whole-genome array
comparative genomic hybridization (aCGH) data. Reanal-
ysis of published aCGH data using this approach supports
association of FCGR3B deletion with increased risk of RA
in a large cohort of 1,982 cases and 3,271 controls (odds
ratio 1.61, P = 2.9×10−3).
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Introduction
Fcγ receptors are a family of cell–surface receptors that are ex-
pressed by a host of different innate and adaptive immune cells, and
mediate inflammatory responses by binding the Fc portion of im-
munoglobulin G (IgG) [Nimmerjahn and Ravetch, 2008]. They can
bedivided into low- andhigh-affinity receptors, basedon their affin-
ity for IgG.Low-affinity receptors areunable tobindmonomeric IgG
and instead bind to polymeric IgG in the form of antigen–antibody
immune complexes. IgGbinding can either activate or inhibit down-
streamcellular responses dependingon theparticular ITAMor ITIM
containing Fcγ receptor that is engaged. Dysregulation of Fcγ re-
ceptors is important in a number of different inflammatory diseases,
including rheumatoid arthritis (RA), systemic lupus erythematosus
(SLE), and Kawasaki disease [Niederer et al., 2010a; McKinney and
Merriman, 2012; Hargreaves et al., 2015b]. Furthermore, not only
are Fcγ receptors critical for disease etiology but also for successful
immunotherapy of patients with hematological and solid cancers
by mediating the effector functions of therapeutic monoclonal an-
tibodies [Dahal et al., 2015].
In humans, there are five low-affinity receptors FcγRIIa, FcγRIIb,
FcγRIIc, FcγRIIIa, and FcγRIIIb encoded by the genes FCGR2A
(MIM# 146790), FCGR2B (MIM# 604590), FCGR2C (MIM#
612169), FCGR3A (MIM# 146740), and FCGR3B (MIM# 610665).
All five genes are encoded within or surrounding an 82.5-kb
tandemly arranged segmental duplication on chromosome 1q23.3
(Fig. 1). There is substantial single-nucleotide variation within and
between the duplicated paralogs, and extensive copy-number vari-
ation involving FCGR3A, FCGR3B, and FCGR2C [Aitman et al.,
2006; Hollox et al., 2009; Machado et al., 2012; Mueller et al., 2012].
The extent of variation has made dissecting the genomic structure
of this region particularly challenging. It is now generally accepted
that copy-number variation is a result of more or fewer copies of
the full 82.5 kb segmental duplication, resulting in the deletion or
duplication of FCGR3A and FCGR2C together, or FCGR3B and
FCGR2C together, but not FCGR2A or FCGR2B, which fall outside
the CNV region [Breunis et al., 2009; Hollox et al., 2009; Mueller
et al., 2012]. The mechanism generating FCGR deletions and dupli-
cations has been shown to be mediated by nonallelic homologous
recombination (NAHR) between the two segmental duplications
with the location of the breakpoint determining whether FCGR3A
or FCGR3B genes are deleted, and whether fusion FCGR2A/C genes
are generated [Machado et al., 2012; Nagelkerke et al., 2015]. The
C© 2016 WILEY PERIODICALS, INC.
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Figure 1. Structure of low-affinity Fc γ receptor region. A: Two 82 kb paralogs repeats with 98.5% identity at chromosome 1p23.3 carry the
low-affinity Fc γ receptor genes FCGR2A, FCGR3A, FCGR2C, FCGR3B, and FCGR2B. B: Nonallelic homologous recombination between paralogs can
generate deletion and duplication alleles where the duplicated allele contains a chimeric copy.
breakpoints of several deletion alleles have been determined and,
although resolution to the exact nucleotide is not possible, break-
points cluster at two points: breakpoint A [Machado et al., 2012],
generatingCNR3 [Nagelkerke et al., 2015]; and breakpoint B, gener-
ating CNR1. Rarer breakpoints, termed CNR2 and CNR4, have also
been observed, and generate FCGR2B pseudogenes and FCGR2C/A
fusion genes [Machado et al., 2012; Nagelkerke et al., 2015]. The ac-
curacy of some of the breakpoint locations is still uncertain; while a
precise localization of each breakpoint is usually impossible, analysis
of fosmid clones frommultiple individuals has suggested a complete
absence of paralog sequence variants (PSVs, i.e., sequence variants
that can always distinguish one paralog from another) in the distal
24.5 kb of each repeat that effectively prohibits higher-resolution
breakpoint mapping in that region [Mueller et al., 2012].
In this context, genetic association studies at this locus that involve
genotyping copy number, sequence variants, or both, can often be
unreliable due to a combination of technical variation due to noisy
assays measuring copy-number variation and biological variation
because of the underlying complexity of the locus [Haridan et al.,
2015; Hargreaves et al., 2015a]. Improved assays based on the par-
alog ratio test (PRT) [Armour et al., 2007] and multiplex ligation
probe amplification (MLPA) [Schouten et al., 2002] have allowed
some studies to suggest an association of the FCGR3B deletion with
SLE [Morris et al., 2010; Niederer et al., 2010b] and RA [Robin-
son et al., 2012]. Importantly, these assays allowed the distinction
of FCGR3B copy number from FCGR3A copy number, although
it should be noted that MLPA does not distinguish the nucleotide
change that defines FCGR3A from FCGR3B. In contrast, the largest
study used array comparative genomic hybridization (aCGH) to
call copy number at this locus in the Wellcome Trust Case Control
Consortium (WTCCC) and failed to find an association [Craddock
et al., 2010]. Crucially, an analysis of the aCGH data did not dis-
tinguish between deletions of FCGR3A and FCGR3B, which would
contribute to a lack of power to observe such an association.
In this study, we develop our understanding of the variation
within this region by reanalyzing the fosmid sequences previously
generated in the light of published findings [Machado et al., 2012;
Nagelkerke et al., 2015]. We investigate the role of gene conversion
in this region and identify new gene conversion alleles. We also
show how awareness of the structure of deletions in this region can
distinguish FCGR3A deletions from FCGR3B deletions in aCGH
data. This allows us to reanalyze aCGH data from RA cases and
Table 1. Samples Previously SequencedAcross the Fcγ Receptor
Region
Fosmid library Population Sample ID Copy number A copy number B copy number
ABC7 YRI NA18517 3 1 2
ABC8 YRI NA18507 4 2 2
ABC9 JPT NA18956 5 2 3
ABC10 YRI NA19240 4 2 2
ABC11 CHB NA18555 5 2 3
ABC12 CEU NA12878 4 2 2
ABC13 YRI NA19129 4 2 2
ABC14 CEU NA12156 4 2 2
healthy controls, and test the association of the FCGR3B deletion
with RA.
Methods
Samples and Data
Four-hundred eighty British samples were obtained from the
Human Random Control series (Public Health England, Porton
Wiltshire, UK). Native American samples were obtained from the
Ashaninka population from five villages along the Junin River in
Central Peru or from theMatsiguenga population living in the com-
munity of Shimaa, Peru. The Ashaninkas and Matsiguengas live in
the Amazon Yunga tropical forest, and speak languages belonging
to the Arawak family. DNA collection was collected under informed
consent and approved by local ethics institutional review boards.
WTCCC data were provided courtesy of the WTCCC Access Com-
mittee and Dr. Matthew Hurles (Wellcome Trust Sanger Institute).
Full details of the cohorts have beenpublishedpreviously [Craddock
et al., 2010]. 454 technology-based sequencing reads were down-
loaded from the European Nucleotide Archive (accession number
ERA168468) in the BAM format. Details of the samples analyzed
are given in Table 1.
454 Sequence Assembly and Alignment
For each fosmid, the reads were mapped to the cloning vector
sequence (cloning vector pEPIFOS-5) using version 0.7.6 of the
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SMALT aligner. Reads mapping to the vector with an alignment
score of less than 30 were retained, and the rest were discarded as
it was assumed they were contaminated with vector sequence. Fil-
tered reads were assembled using version 2.9 of the GS De Novo
Assembler (newbler). The assembled contigs labeled as large by
the assembler were retained. Filtered reads were mapped to these
contigs, and the consensus algorithm of GAP5 version 2.0.0b10
[Bonfield and Whitwham, 2010] was used to recompute the con-
tig consensus sequences. Paralogs A (chr1:159815745-159831746)
andB (chr1:159897573-159913518)were extracted from the human
reference genome hg18. The assembled contigs weremapped to par-
alogs A and B using the MEM algorithm of the Burrows-Wheeler
aligner [Li, 2013]. Alignments spanning less than 400 bases on the
reference were discarded. For each sample and paralog, a maximal
nonoverlapping set of alignments was kept and the rest of the align-
ments were discarded. The sequence identity (fraction of matching
aligned bases) between the sample and reference paralogs was com-
puted using the aligned contigs, and each contig was assigned to
the paralog of the highest sequence identity. For each fosmid, the
contigs chosen for the paralog assigned via identity were extracted
in reference order and concatenated to obtain a single sequence rep-
resenting the fosmid. Sequence from fosmids including sequence
from the distal 16 kb region of either reference B or reference A,
excluding alignment gaps, was used to compute amultiple sequence
alignment by Clustal Omega [Sievers et al., 2011]. The multiple
sequence alignment was used to construct a median network by
SplitsTree version 4.14.2 [Huson and Bryant, 2006].
FCGR 3 Copy Number Typing and Breakpoint Sequencing
Following FCGR3 typing using a PRT/REDVR approach, as de-
scribed previously [Hollox et al., 2009], two homozygous deleted
individuals were identified from480UK individuals and selected for
further analysis. PCR products spanning the region, as previously
described [Machado et al., 2012], were end-sequenced to determine
the approximate location of breakpoints. PCR products spanning
the breakpoint region were comprehensively sequenced by Sanger
sequencing.
aCGH Analysis
Quantile-normalized log ratio data from Agilent 2×105K aCGH
experiments were used [Conrad et al., 2009; Craddock et al., 2010].
Including technical duplicates, a total of 21,858 aCGH experiments
were analyzed using the software CNVtools 1.42.3 [Barnes et al.,
2008] implemented in R v.3.1.1 [The R Development Team, 2013].
Briefly, the first principal component (PC) of the data is fitted to a
Gaussian mixture model, with three components, corresponding to
normal, deletion, and duplication. Cohort is included as a factor in
the mixture model to minimize differential bias in calling between
cohorts. The mixture model then allows calling of copy number
combined with a posterior probability of that call. A total of 1,363
samples with a deletion were called, and a subset verified against
samples also typed by the paralog ratio test.
PC analysis on a narrower set of aCGH probes (see Results) was
conducted using CNV tools on RA and control individuals showing
heterozygous deletion, and a Gaussian mixture model run with two
components to attempt to stratify FCGR3B deletions and FCGR3A
deletions on the basis of values on the first PC, and case/control
status included as a factor in the mixture model to minimize dif-
ferential bias in calling between cohorts. In all analyses, the values
from each aCGH probe were weighted equally.
Association Analysis
Odds ratios and significanceof departure fromthenull hypothesis
were calculated from two-by-two contingency tables using Fisher’s
exact test, implemented in R.
Results
De Novo Assembly of High-Throughput Sequencing Reads
Supports a Simple NAHR Model for CNV and Patches of
Gene Conversion
Cloning diploid genomes into large- andmedium-size insert vec-
tors, such as fosmids, provides an approach to characterizemedium-
scale structural variation, such as the copy-number variation involv-
ing the low-affinity Fcγ receptor region. Previously, fosmid libraries
were generated for eight individuals from the HapMap collection,
and fosmids mapping to the Fcγ region fully sequenced using 454
sequencing technology [Kidd et al., 2008; Mueller et al., 2012]. Af-
ter de novo assembly of contigs, the sequence reads were mapped
directly to the reference genome. It had been suggested that further
resolution of the region where most FCGR3B deletion breakpoints
mapped was limited by the lack of sequence variants distinguish-
ing A paralog sequences from B paralog sequences [Mueller et al.,
2012]. It was therefore important to investigate this before pursu-
ing further breakpoint mapping in this region. We used a novel
approach to assign sequence contigs, which together comprised a
fosmid sequence, to either A or B paralog sequences, and to investi-
gate potential switches between A-like and B-like sequences within
a fosmid.Mapping of the whole fosmid allowed assignment to a two
copy, one copy, or three copy chromosome depending on the geno-
type of individual from whom the fosmid library was derived. Our
fosmid mapping locations matched all those previously published
[Mueller et al., 2012]. Because some of the fosmids overlapped with
single copy sequence flanking the duplicated region, this mapping
information provided a further check that our fosmid assignment
to A (proximal) or B (distal) paralog was correct. We confirmed two
clones to be from the duplicated allele of sample ABC11 (NA18555),
and confirm that these are the reciprocal products expected from
a model of NAHR, with a breakpoint similar to previous deletion
breakpoints (Fig. 2).
We observed evidence of gene-conversion alleles by examin-
ing fosmid sequences. Three different alleles were initially found:
an A to B gene conversion of about 9.1 kb (NC 000001.9:g.
159806619 159815757con159888461 159897571), the recipro-
cal B to A gene conversion of 9.1 kb (NC 000001.9:g.
159888461 159897571con159806619 159815757), and a smaller
B to A gene conversion of 2.4 kb (NC 000001.9:g.159888397-
159890836con159806551 159808988). All three gene conversions
occur between FCGR3A/B and FCGR2B/C in the region previously
identified as a deletion breakpoint region [Machado et al., 2012;
Mueller et al., 2012; Nagelkerke et al., 2015] (Fig. 3; Table 2). While
these events would explain the proximal part of the 24.5 kb that
was previously suggested to show no nonpolymorphic PSVs, we
sought to investigate the remaining diversity of the distal16kb.We
therefore took the sequences corresponding to this region from the
fosmids that we assembled, for both A and B paralogs, aligned them
together, and constructed a median network from the alignment
(Fig. 4). From this network, it is clear that sequences that derive from
the A paralog are clearly distinguishable from the sequences that de-
rive from the B paralog. Five A paralog fosmid sequences, from two
alleles from samples ABC12 (NA12878) and ABC13 (NA19129),
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Figure 2. Duplication NAHR breakpoints in fosmid sequences. Duplications formed by NAHR will result in a chimeric paralog containing A and
B sequences. Sample ABC11 (NA18555) is heterozygous for FCGR3B duplication. Two fosmids, both generated from one allele, show the NAHR
breakpoint. The inferred location of the breakpoint (hg18) is shown, and apparently differs by 412 bp only because of the different sequence
contigs constructed (see Methods). The lines show alignment of the fosmid contig sequences to A and B reference sequences, with the number
of mismatches to A and B shown above and below the line, respectively.
share more sequence with the B repeat sequences than other A par-
alog sequences. Inspection of our contig alignment calls suggests
that O14 ABC12 has a fourth gene-conversion allele that converts
A sequences to B-like sequence for about 7 kb, although the region
cannot be well defined due to extensive sequence similarity in the
region between the two paralogs (which we call an indistinct gene-
conversion allele; Table 2). The sequences from ABC13 fosmids that
are distinct from the main A paralog cluster show a 6.4-kb patch
of sequence highly diverged from both A and B paralog reference
sequences (which we call a highly diverged region; Table 2).
Although these gene-conversion alleles may complicate assess-
ment of breakpoint position in certain circumstances, the phyloge-
netic network (Fig. 4) shows that A paralog sequences are clearly
distinguishable from B paralog sequences. This shows that A and
B sequences can be distinguished by sequence differences alone,
which does not support the observation of the 24.5-kb region of
haplotype swapping model previously proposed. The data support
our sequence-based approach for mapping NAHR breakpoints in
the region.
Analysis of Deletion Breakpoints in British and Shimaa
Populations Show Population-Specific Breakpoints
Previously, mapping deletion breakpoints in a globally diverse se-
lection of alleles suggested that different deletion breakpoints were
distinct yet clustered into two major hotspot regions [Machado
et al., 2012]. Given that each one was distinct, this strongly sug-
gested identity-by-state rather than identity by descent. However, it
may be the case that within a single population, all deletion alleles
are identical by descent because of the closer genetic ancestry be-
tween members of the same population. To answer this question,
we screened three distinct populations for individuals homozygous
for either FCGR3A deletion, FCGR3B deletion, or heterozygous for
FGCR3A and FCGR3B deletions. We chose the British as one pop-
ulation, which is an outbred population at the edge of northwest
Europe, for two reasons. First, we had not previously mapped a Eu-
ropean deletion allele, yetmost genetic association studies involving
the FCGR3B deletion alleles are on European populations [McK-
inney and Merriman, 2012]. Second, many studies of disease asso-
ciation at this locus are on British cohorts, or cohorts with British
ancestry [Bournazos et al., 2010;McKinney et al., 2010;Morris et al.,
2010; Niederer et al., 2010b; Robinson et al., 2012]. Understanding
the structure of the different deletion alleles will allow distinction
of alleles that are likely to be identical by descent from those that
are identical by state, and potentially allow refinement of disease
associations.
Using PRT, we identified two UK samples that were homozygous
for the FCGR3B deletion. Sequence analysis showed that both were
heterozygous for the NAHR breakpoint, with one allele showing
a breakpoint in region B, generating CNR1, and the other in a
region distal to breakpoint B, generating CNR4 (Fig. 5; Table 2).
The breakpoint generating CNR4was particularly difficult to define
due to the lack of informative variable sites. Using an eight-SNP
haplotype we have previously defined [Machado et al., 2012] (Supp.
Tables S1 and S2) that is just distal to the CNV region, both UK
samples proved to be heterozygous for two common haplotypes.
Taken together, this strongly suggests that these FCGR3B deletion
alleles are identical-by-state, but have been generated by at least
three independent mutational events (Supp. Fig. S1).
We also chose the Shimaa and Ashaninka—two isolated native
American groups resident in Peru that have an unusually high
frequency of FCGR3B deletion alleles (27% in Shimaa, 18% in
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Figure 3. Gene-conversion alleles identified in fosmid sequences. Representative fosmids of seven alleles carrying gene conversions are shown.
Inferred breakpoints relative to hg18 paralog A and paralog B are shown. The lines show alignment of the fosmid sequences to A and B reference
sequences, with the number of mismatches to A and B shown above and below the line, respectively. The first four alleles are identical, showing a
9.1-kb B sequence on the A paralog. The following two show the reciprocal event, a 9.1-kb A sequence on the B paralog. The final example shows
a 2.4-kb B sequence on an A paralog.
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Table 2. Chromosomal Locations of Genomic Features Described in This Paper
Feature Location (hg18)a
9.1 kb gene-conversion alleles NC 000001.9:g.159806619 159815757con159888461 159897571
NC 000001.9:g.159888461 159897571con159806619 159815757
2.4 kb gene-conversion allele NC 000001.9:g.159888397 159890836con159806551 159808988
Indistinct gene-conversion allele Chr1:159824746–159831747
Highly diverged region Chr1:159824223–159830623
Region used for multiple alignment and phylogenetic network Chr1:159815745–159831746
UK deletion breakpoint regions Chr1: 159801233–159801500
Chr1: 159823772–159825582
Chr1: 159805059–159805132
Native American deletion breakpoint regions Chr1: 159775888–159775907
Chr1: 159809793–159821996
Chr1: 159811450–159823429
aRegions are given on the A paralog, but depending on the nature of the feature, the corresponding B paralog may also be affected. See text for details.
Ashaninka) [Zuccherato, 2012]. We selected seven individuals who
were homozygous for FCGR3B deletions, and one individual who
carried both a FCGR3A deletion and a FCGR3B deletion. Using a
PCR amplification and Sanger sequencing approach, we located all
the deletion breakpoints from the FCGR3B deletion homozygotes
to a 10-kb region immediately distal to the gene-conversion region
(Fig. 5). Because of the scarcity and ambiguity of PSVs within this
region, particularly in native Americans, we could not refine this
breakpoint further, although a breakpoint in this region has been
previously observed in other populations [Machado et al., 2012].
All seven FCGR3B breakpoints were homozygous and identical for
variant sites within this region strongly suggesting that the alleles in
these populations were identical by descent. In the individual who
carried a FCGR3A deletion and a FCGR3B deletion, the FCGR3B
deletion breakpoint was mapped to the same region as the others,
but a gene conversion event on one of the two homologous chro-
mosomes obscured the breakpoint region. The FCGR3A deletion
mapped to a region previously identified as breakpoint A [Machado
et al., 2012], consistent with previous studies. Analysis of the eight-
SNP haplotype showed that all individuals were homozygous for
the common haplotype in South Americans (Supp. Tables S2 and
S3). Because of this, we cannot distinguish identity-by-state from
identity-by-descent on eight-SNP haplotype data alone.
Reanalysis of aCGH Data Allows Discrimination of FCGR3A
and FCGR3B Deletions
Based on the data presented here and previously, it is a reasonable
assumption that all FCGR3B deletion alleles share the same or very
similar NAHR breakpoints at one or more NAHR hotspots at the
distal end of the paralogs. Previous work, together with a single
observation in this work, has shown that FCGR3A deletion alleles
also share a breakpoint hotspot [Machado et al., 2012]. If we repre-
sent heterozygous individuals for these deletions (Fig. 6A), it can be
seen that all heterozygous deletion genotypes will have a common
region absent, but will also have regions absent uniquely in FCGR3B
deletions and uniquely in FCGR3A deletions. We can also propose
that the effectiveness of hybridization of particular aCGH probes
that were designed to the A or B paralogs region will be influenced
not only by total copy number of the duplicated region but also by
sequence differences between FCGR3A copy and FCGR3B copy of
the paralogs region, because of the sequence differences in those
aCGH probes. Probes designed to hybridize to FCGR3A will also
hybridize to FCGR3B, but more weakly, and vice versa.
We therefore initially called copy number of FCGR3A and
FCGR3B in samples across the entireWTCCC dataset, and the CEU
HapMap cohort included in the same aCGH experiment using 33
probes spanning both A and B paralogs. We then used a Gaussian
mixture model to categorize samples into those carrying duplica-
tions, deletions, and those with the normal diploid copy number of
two FCGR3B genes and two FCGR3A genes (Fig. 6B). It should be
noted that the data quality, reflected in the extent to which different
copy numbers clustered in the histogram, varied between different
cohorts and, for this reason, only three components of the mixture
model were used representing loss, normal or gain of copy number.
We then selected 20 aCGH probes that are a subset of the orig-
inal 33 probes and that map only to the FCGR3A and FCGR3B
deletion-determining regions (Fig. 6A). We selected the individu-
als that showed deletion copy-number values in the control and RA
case cohorts (a total of 388 individuals comprising 170RA cases, 204
controls, 14 CEU samples). We took these individuals and removed
13 individuals with extremely low copy number (PC1 value>3.8,
seven from the cases, six from the controls) who will be deletion
homozygotes and therefore could not be categorized into FCGR3A
or FCGR3B deletions using our approach (Fig. 6B).We then applied
PC analysis on the raw aCGH data from the remaining 375 indi-
viduals, expecting that because they have the same copy number,
the probe intensity variation represented by the first PC will now be
primarily due to sequence differences between FCGR3B deletions
and FCGR3A deletions. On plotting the PC1 as a histogram, most
samples cluster as a single group to the right of the plot with a few
outliers to the left, which on larger cohorts begin to form a distinct
peak. Using aGaussianmixturemodel approach to split the data, we
categorize the deletion samples into two groups that, based on 100%
concordance with 15 known FCGR3B and FCGR3A deletions typed
using PRT/REDVR, represent FCGR3A heterozygous deletions (Fig.
6C) and FCGR3B heterozygous deletions (Fig. 6C).
RA Is Associated with FCGR3B Deletion
Using the approach above, we called heterozygous FCGR3B
deletion individuals for the RA cohort and the control cohorts
(Table 3; Supp. Table S4). Comparison of deletion heterozygote
frequencies in cases and controls supported the association of RA
with the FCGR3B deletion allele (OR 1.61, 95% CI 1.16–2.24,
P = 2.9×10–3, Fisher’s exact test).
Discussion
Our data show that for the two UK samples homozygous for
the FCGR3B deletion (CO092 and UKTS8802), the breakpoints all
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map to the same regions as previously identified [Machado et al.,
2013; Nagelkerke et al., 2015]. However, two of the UK deletion
alleles appear to have the same breakpoints, suggesting that these
deletion alleles are identical-by-descent. The other two UK deletion
alleles show different deletion breakpoints, are therefore identical-
by-state, andare likely tohavebeengeneratedby recurrentmutation.
This is supported by a mutation rate estimated at between 0.03%
and 0.14% per generation at this locus [Machado et al., 2012]. In
two endogamous populations from Peru, where a high frequency
of FCGR3B deletion alleles has been reported [Zuccherato, 2012],
we found that seven out of eight FCGR3B deletion breakpoints
were identical, showing that these deletions in these populations
are identical by descent. Therefore, in outbred populations, a com-
bination of identity-by-descent and identity-by-state is the norm.
However, with increased levels of endogamy in the population, re-
current sampling of the identical-by-descent deletion alleles is more
likely.
We also identify the reciprocal duplication breakpoint generated
by NAHR within this region from analysis of the fosmid sequence,
as predicted by the NAHR model. We found three gene conversion
alleles within the region that contains the FCGR3B deletion break-
points. It is likely that the longer region of gene conversion is more
likely to have been generated by a double crossover event, although
long gene-conversion tracts are known to exist [Chen et al., 2007;
Hallast et al., 2013].
The FCGR3B deletion allele has been shown to be associated
with RA in several studies. In some studies, the association is with
all forms of RA [McKinney et al., 2010; Graf et al., 2012]; in oth-
ers, the effect is more pronounced in autoantibody-positive RA
[Robinson et al., 2012]. However, other studies failed to find an
association [Chen et al., 2007; Mamtani et al., 2010; Marques et al.,
2010], and all studies have been limited by noisy typing of FCGR3B
copy number and/or small sample sizes that are likely to be under-
powered. In this study, we replicate an association of the FCGR3B
Figure 4. Median network of distal 16 kb fosmid sequences from A and B paralogs. Thirty-three fosmid sequences corresponding to the distal
16 kb of both A and B paralogs were aligned, together with the hg18 human reference sequences for the A and B paralogs, and their relationships
plotted as an unrooted median network. Sequences that are from fosmids mapping to the A paralog and B paralog are highlighted in the ellipses.
Scale bar indicates 10 single-nucleotide substitutions.
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Figure 5. Fcγ receptor deletion breakpoint mapping. A: Schematic of PCR amplicons used to amplify the Fc γ receptor region in homozygous
deletion individuals, as previously carried out [Machado et al., 2012]. B: Breakpoint mapping of two British individuals (UKTS8802 and C0092),
homozygous for FCGR3B deletion. For each individual, both alleles (labeled as 1 and 2, on the right of each diagram) are shown. The overlapping
PCR amplicons spanning the duplication are shown in the center, with the amplicon number showing the amplicon in which that particular
breakpoint was found. Each amplicon containing the breakpoint is expanded (shown by the blue brackets above and below the PCR amplicons),
showing the position of the PSVs as well as the hg18 chromosome 1 coordinates. A change in color from red (A-like) to blue (B-like) indicates
the location of the breakpoint. If the breakpoint position is not clear, due to gene-conversion events or possible recurrent NAHR events, the PSVs
in the putative breakpoint region are colored black. C: Breakpoint mapping of eight native American individuals, seven homozygous for FCGR3B
deletion, and one heterozygous for FCGR3A deletion and FCGR3B deletion. Individuals prefixed SH areMatsiguenga individuals, and those prefixed
ASH are Ashaninka individuals.
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Figure 6. Analysis of Fcγ receptor region using array CGH data. A: The principle of selecting aCGH probes that are more likely to distinguish
between FCGR3A and FCGR3B deletions. B: Clustering of aCGH data into deletion, duplication, and normal copy-number clusters using Gaussian
mixture modeling. Cohort labels: 58C, 1,958 cohort; NBS, National Blood Service cohort; CEU, CEPH Europeans from Utah; RA, rheumatoid arthritis
cohort. C: Separation of deletion heterozygotes into deletions of FCGR3B and FCGR3A by fitting two Gaussian curves to the data.
Table 3. Association Analysis of FCGR3B Deletion and Rheuma-
toid Arthritis
Genotype RA Control OR (95% confidence interval) P value
FCGR3B deletion carriers 79 82 1.61 (1.16–2.24) 2.9×10–3
Noncarriers 1,903 3,189
deletion allele with RA (Fisher’s exact test, P = 2.9×10–3) in a large
cohort of 1,982 cases and 3,271 controls, which is three times the
size of the largest previous study. Furthermore, an odds ratio of
1.61 (95% CI 1.16–2.24) is a size of effect consistent with previous
studies.
Nevertheless, this study has limitations. First, the distinction be-
tween FCGR3A and FCGR3B deletions using aCGH data is not
absolutely clear, so there may be some misclassification of FCGR3A
and FCGR3B deletions where signals are at the boundary of the
two Gaussian curves in the mixture model. Second, as we have
shown, FCGR3B deletion alleles can have different breakpoints in
the UK population, and it is probable that structurally different
alleles will have different effects on RA risk. Indeed, a previous
study has suggested that the association of inflammatory disease
with FCGR3B CN may not be due to the loss of FCGR3B as such,
but rather the juxtaposition of FCGR2C regulatory elements next
to a full FCGR2B coding sequence, causing ectopic expression of
the inhibitory receptor FCGR2B on NK cells [Mueller et al., 2012].
If this is correct, one or more PSVs distinguishing A from B para-
log repeats must lead to ectopic expression on NK cells, but these
functional sequence changes have not yet been identified. An al-
ternative explanation for the association is that certain deletion
breakpoints generate FCGR2C/B fusion genes, including a FCGR2B
null variant [Nagelkerke et al., 2015]. We have shown that upstream
and coding regions of both FCGR2B and FCGR2C are affected by
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gene-conversion events, and the role of gene conversion in modu-
lating variation in gene expression in deleted and nondeleted chro-
mosomes remains to be determined.
Recent studies have shown that some structural variation can
be imputed from flanking dense SNP haplotypes [Sekar et al.,
2016]. This enables reanalysis of huge cohorts that have undergone
genome-wide SNP typing, indirectly imputing structural variants
and testing those imputed variants for association with a pheno-
type. While there is no simple tagging SNP for FCGR3B deletion
alleles [Hollox et al., 2009], it is possible that copy-number and
gene-conversion alleles can be indirectly imputed from flanking
SNP haplotypes. If so, the nature of the association between genetic
variation at this locus andRA, as well as other autoimmune diseases,
can be resolved.
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